TRV GP III, LLC
- SEC CIK
- 0001637299
- Latest filing
- Feb 14, 2024
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 5, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 7
- 0 vs. Q2 2021
- Portfolio value
- $526.8M
- −$46.0M (−8.0%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 5,524,031 | $152.0M | 28.8% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 4,962,202 | $140.0M | 26.6% | −1,000,000−16.8% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 5,839,160 | $98.6M | 18.7% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 2,422,549 | $72.6M | 13.8% | −1,000,000−29.2% | Reduced | History |
| DBTXDecibel Therapeutics, Inc. | COM | 3,139,685 | $24.2M | 4.6% | 00.0% | Unchanged | History |
| JNCEJounce Therapeutics, Inc. | COM | 3,048,780 | $22.7M | 4.3% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 6,391,176 | $16.8M | 3.2% | 00.0% | Unchanged | History |